ResearcherTexas Tech University Health Sciences CenterNo recent work listed

Tugba Mehmetoglu-Gurbuz

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0003-1417-9446; OpenAlex author ID A5020817423.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis. First author DOI 10.3390/antiox12101791 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Ramadevi Subramani · 1 shared paper, 2023
- Paper Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis. DOI 10.3390/antiox12101791 ↗
Karla L. Perez · 1 shared paper, 2023
- Paper Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis. DOI 10.3390/antiox12101791 ↗
Rajkumar Lakshmanaswamy · 1 shared paper, 2023
- Paper Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis. DOI 10.3390/antiox12101791 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.